1-5 of 5
Evi Lianidou
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis

Open Access
Wolfgang Janni, Thomas W.P. Friedl, Tracy C. Yab, Francois-Clément Bidard, Massimo Cristofanilli, Daniel F. Hayes, Michail Ignatiadis, Meredith M. Regan, Catherine Alix-Panabieres, William E. Barlow, Carlos Caldas, Lisa A. Carey, Luc Dirix, Tanja Fehm, Jose A. Garcia-Saenz, Paola Gazzaniga, Daniele Generali, Lorenzo Gerratana, Rafael Gisbert-Criado, William Jacot, Zefei Jiang, Simon A. Joosse, Evi Lianidou, Rafael López López, Mark J.M. Magbanua, Luis Manso, Dimitris Mavroudis, Volkmar Müller, Elisabetta Munzone, Klaus Pantel, Jean-Yves Pierga, Brigitte Rack, Sabine Riethdorf, Hope S. Rugo, Kostandinos Sideras, Stefan Sleijfer, Jeffrey Smerage, Justin Stebbing, Leon W.M.M. Terstappen, Jose Vidal-Martínez, Markus Wallwiener, Karthik V. Giridhar, Minetta C. Liu
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (11): 2196–2209.
https://doi.org/10.1158/1078-0432.CCR-24-3108
Published: 03 June 2025
View article titled, Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis
Open the PDF for Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis in another window
Includes: Supplementary data
Journal Articles

ESR1 Methylation: A Liquid Biopsy–Based Epigenetic Assay for the Follow-up of Patients with Metastatic Breast Cancer Receiving Endocrine Treatment

Free
Sophia Mastoraki, Areti Strati, Eleni Tzanikou, Maria Chimonidou, Eleni Politaki, Alexandra Voutsina, Amanda Psyrri, Vassilis Georgoulias, Evi Lianidou
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (6): 1500–1510.
https://doi.org/10.1158/1078-0432.CCR-17-1181
Published: 14 March 2018
View article titled, ESR1 Methylation: A Liquid Biopsy–Based Epigenetic Assay for the Follow-up of Patients with Metastatic Breast Cancer Receiving Endocrine Treatment
Open the PDF for ESR1 Methylation: A Liquid Biopsy–Based Epigenetic Assay for the Follow-up of Patients with Metastatic Breast Cancer Receiving Endocrine Treatment in another window
Includes: Supplementary data
Journal Articles

PIK3CA Mutational Status in Circulating Tumor Cells Can Change During Disease Recurrence or Progression in Patients with Breast Cancer

Free
Athina Markou, Sofia Farkona, Christina Schiza, Tonia Efstathiou, Sophia Kounelis, Nikos Malamos, Vassilis Georgoulias, Evi Lianidou
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (22): 5823–5834.
https://doi.org/10.1158/1078-0432.CCR-14-0149
Published: 13 November 2014
View article titled, PIK3CA Mutational Status in Circulating Tumor Cells Can Change During Disease Recurrence or Progression in Patients with Breast Cancer
Open the PDF for PIK3CA Mutational Status in Circulating Tumor Cells Can Change During Disease Recurrence or Progression in Patients with Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Prognostic Value of the Molecular Detection of Circulating Tumor Cells Using a Multimarker Reverse Transcription-PCR Assay for Cytokeratin 19, Mammaglobin A, and HER2 in Early Breast Cancer

Free
Michail Ignatiadis, Galatea Kallergi, Maria Ntoulia, Maria Perraki, Stella Apostolaki, Maria Kafousi, Grigorios Chlouverakis, Efstathios Stathopoulos, Evi Lianidou, Vassilis Georgoulias, Dimitris Mavroudis
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (9): 2593–2600.
https://doi.org/10.1158/1078-0432.CCR-07-4758
Published: 01 May 2008
View article titled, Prognostic Value of the Molecular Detection of Circulating Tumor Cells Using a Multimarker Reverse Transcription-PCR Assay for Cytokeratin 19, Mammaglobin A, and HER2 in Early Breast Cancer
Open the PDF for Prognostic Value of the Molecular Detection of Circulating Tumor Cells Using a Multimarker Reverse Transcription-PCR Assay for Cytokeratin 19, Mammaglobin A, and HER2 in Early Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Trastuzumab Administration Can Effectively Target Chemotherapy-Resistant Cytokeratin-19 Messenger RNA–Positive Tumor Cells in the Peripheral Blood and Bone Marrow of Patients With Breast Cancer

Free
Vassiliki Bozionellou, Dimitris Mavroudis, Maria Perraki, Savvas Papadopoulos, Stella Apostolaki, Efstathios Stathopoulos, Aliki Stathopoulou, Evi Lianidou, Vassilis Georgoulias
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (24): 8185–8194.
https://doi.org/10.1158/1078-0432.CCR-03-0094
Published: 28 December 2004
View article titled, Trastuzumab Administration Can Effectively Target Chemotherapy-Resistant Cytokeratin-19 Messenger RNA–Positive Tumor Cells in the Peripheral Blood and Bone Marrow of Patients With Breast Cancer
Open the PDF for Trastuzumab Administration Can Effectively Target Chemotherapy-Resistant Cytokeratin-19 Messenger RNA–Positive Tumor Cells in the Peripheral Blood and Bone Marrow of Patients With Breast Cancer in another window